Literature DB >> 28698146

Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.

Minoru Terashima1, Akihiko Ishimura1, Sasithorn Wanna-Udom1, Takeshi Suzuki2.   

Abstract

Histone methylation is associated with various biological and pathological processes including cancer development. KDM6A is a candidate tumor suppressor gene that encodes a histone H3 lysine 27 (H3K27) demethylase. In this study, we discovered that ectopic expression of KDM6A antagonized TGF-β-induced epithelial-mesenchymal transition (EMT) and cell migration of lung cancer cell lines through its demethylase activity. KDM6A counteracted TGF-β-dependent changes in the expression of EMT-related genes such as CDH1/E-cadherin, FN1/Fibronectin, ZEB family and microRNA-200 family. Mechanistic investigations revealed that KDM6A inhibited the recruitment of EZH2 histone H3K27 methyltransferase and H3K27 methylation on the regulatory regions of the target genes such as CDH1 and microRNA-200 family. Knockdown of KDM6A did not proceed EMT by itself, but influenced the expression of specific target genes critical for EMT, suggesting that endogenous KDM6A was involved in EMT-inducing transcriptional program. This study demonstrated a novel regulatory role of KDM6A histone demethylase in the epigenetic control of EMT process in lung cancer cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer biology; Epithelial-mesenchymal transition; Histone methylation; MicroRNA; Transcriptional regulation

Mesh:

Substances:

Year:  2017        PMID: 28698146     DOI: 10.1016/j.bbrc.2017.07.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.

Authors:  Minoru Terashima; Akihiko Ishimura; Sasithorn Wanna-Udom; Takeshi Suzuki
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

2.  KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.

Authors:  Sasithorn Wanna-Udom; Minoru Terashima; Kusuma Suphakhong; Akihiko Ishimura; Takahisa Takino; Takeshi Suzuki
Journal:  J Biol Chem       Date:  2020-12-24       Impact factor: 5.157

Review 3.  Tumor metastasis: Mechanistic insights and therapeutic interventions.

Authors:  Mengmeng Liu; Jing Yang; Bushu Xu; Xing Zhang
Journal:  MedComm (2020)       Date:  2021-12-02

Review 4.  Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets.

Authors:  Khuloud Bajbouj; Abeer Al-Ali; Rakhee K Ramakrishnan; Maha Saber-Ayad; Qutayba Hamid
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

5.  KDM6A missense variants hamper H3 histone demethylation in lung squamous cell carcinoma.

Authors:  Tommaso Biagini; Francesco Petrizzelli; Salvatore Daniele Bianco; Niccolò Liorni; Alessandro Napoli; Stefano Castellana; Angelo Luigi Vescovi; Massimo Carella; Viviana Caputo; Tommaso Mazza
Journal:  Comput Struct Biotechnol J       Date:  2022-06-18       Impact factor: 6.155

Review 6.  Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers.

Authors:  Gaya Punnia-Moorthy; Peter Hersey; Abdullah Al Emran; Jessamy Tiffen
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

Review 7.  Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges.

Authors:  Yuchen Chen; Xinran Liu; Yangkai Li; Chuntao Quan; Ling Zheng; Kun Huang
Journal:  Comput Struct Biotechnol J       Date:  2018-06-20       Impact factor: 7.271

Review 8.  KDM6 Demethylases and Their Roles in Human Cancers.

Authors:  Chunyan Hua; Jiaqing Chen; Shuting Li; Jianan Zhou; Jiahong Fu; Weijian Sun; Wenqian Wang
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

9.  Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype.

Authors:  Laura Lecce; Yang Xu; Bhargavi V'Gangula; Nirupama Chandel; Venu Pothula; Axelle Caudrillier; Maria Paola Santini; Valentina d'Escamard; Delaine K Ceholski; Przemek A Gorski; Lijiang Ma; Simon Koplev; Martin Mæng Bjørklund; Johan Lm Björkegren; Manfred Boehm; Jacob Fog Bentzon; Valentin Fuster; Ha Won Kim; Neal L Weintraub; Andrew H Baker; Emily Bernstein; Jason C Kovacic
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.